Guanfu Holding Co., Ltd. logo

Guanfu Holding Co., Ltd. (002102)

Market Closed
20 Dec, 06:57
XSHE XSHE
¥
2. 88
+0.07
+2.49%
¥
7.19B Market Cap
- P/E Ratio
0.2% Div Yield
89,590,860 Volume
- Eps
¥ 2.81
Previous Close
Day Range
2.84 3.05
Year Range
1.88 3.39
Want to track 002102 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

002102 Chart

Guanfu Holding Co., Ltd. Profile

Conglomerates Industry
Industrials Sector
- CEO
XSHE Exchange
CNE000001Q28 ISIN
China Country
992 Employees
- Last Dividend
12 Oct 2016 Last Split
- IPO Date

Overview

HuBei NengTer Technology CO.,Ltd is a multifaceted company that operates primarily in the ecommerce space, focusing on the supply chain of plastic raw materials within China. Its operations extend beyond ecommerce into the research and development, production, and sales of pharmaceutical intermediates, illustrating a diversified business model that encompasses various industries. Historically known as Guanfu Holding Co., Ltd., the company underwent a rebranding to better reflect its broadened scope and innovative drive. Founded in 1999 and centered in Jingzhou, China, HuBei NengTer Technology CO.,Ltd has also ventured into real estate leasing and gold mining, showcasing an ambitious expansion of its business operations and investment strategies.

Products and Services

  • Ecommerce Platform for Plastic Raw Materials:

    At the core of its operations, HuBei NengTer Technology supplies plastic raw materials through an advanced ecommerce platform. This digital marketplace serves the intricate supply chain needs of China's booming manufacturing industry, providing a critical resource for various sectors reliant on high-quality plastic materials.

  • Pharmaceutical Intermediates:

    The company's engagement in the pharmaceutical sector is marked by its research and development, production, and sales of key pharmaceutical intermediates. These include:

    • Montelukast Sodium Intermediates: Essential for the production of medications used in the treatment of asthma and allergic rhinitis.
    • Rosuvastatin Series Intermediates: Used in the synthesis of statins, specifically rosuvastatin, which is a cholesterol-lowering medication.
    • Vitamin E and Its Intermediates: Vital for manufacturing vitamin E supplements, which are crucial for various bodily functions and protecting cells from damage.
  • Real Estate Leasing:

    In diversifying its portfolio, HuBei NengTer Technology has ventured into real estate, offering leasing services. This aspect of the business represents the company's strategic investment in the stable and potentially lucrative real estate market, contributing to its revenue stream and expanding its corporate footprint.

  • Gold Mining:

    Rounding off its multilayered business model, the company partakes in gold mining activities. This operation underscores HuBei NengTer Technology's investment in natural resources and its aim to capitalize on the valuable commodities sector, further enhancing its diversified market presence.

Contact Information

Address: Building 8
Phone: 86 71 6802 9666